With prescription drugs inhibiting CYP3A to the lesser, but still considerable degree, estazolam must be utilized only with warning and consideration of correct dosage reduction. The following are samples of medicines acknowledged to inhibit the metabolism of other associated benzodiazepines, presumably via inhibition of CYP3A: nefazodone, fluvoxam

nirmatrelvir will boost the stage or outcome of triazolam by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.Avoid concomitant use of tucatinib with CYP3A substrates, the place negligible concentration modifications may well produce severe or daily life-threatening toxicities. If unavoidable, lower CYP3A substrate dose accord